1
|
Tafuri WL, Tomokane TY, Silva AMG, Kanashiro‐Galo L, Mosser DM, Quaresma JAS, Pagliari C, Sotto MN. Skin fibrosis associated with keloid, scleroderma and Jorge Lobo's disease (lacaziosis): An immuno-histochemical study. Int J Exp Pathol 2022; 103:234-244. [PMID: 36183172 PMCID: PMC9664412 DOI: 10.1111/iep.12456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2021] [Revised: 07/08/2022] [Accepted: 07/27/2022] [Indexed: 11/30/2022] Open
Abstract
Fibrosis is a common pathophysiological response of many tissues and organs subjected to chronic injury. Despite the diverse aetiology of keloid, lacaziosis and localized scleroderma, the process of fibrosis is present in the pathogenesis of all of these three entities beyond other individual clinical and histological distinct characteristics. Fibrosis was studied in 20 samples each of these three chronic cutaneous inflammatory diseases. An immunohistochemical study was carried out to explore the presence of α-smooth muscle actin (α-SMA) and vimentin cytoskeleton antigens, CD31, CD34, Ki67, p16; CD105, CD163, CD206 and FOXP3 antigens; and the central fibrotic cytokine TGF-β. Higher expression of vimentin in comparison to α-SMA in all three lesion types was found. CD31- and CD34-positive blood vessel endothelial cells were observed throughout the reticular dermis. Ki67 expression was low and almost absent in scleroderma. p16-positive levels were higher than ki67 and observed in reticular dermis of keloidal collagen in keloids, in collagen bundles in scleroderma and in the external layers of the granulomas in lacaziosis. The presence of α-actin positive cells and rarely CD34 positive cells, observed primarily in keloids, may be related to higher p16 antigen expression, a measure of cell senescence. Low FOXP3 expression was observed in all lesion types. CD105-positive cells were mainly found in perivascular tissue in close contact with the adventitia in keloids and scleroderma, while, in lacaziosis, these cells were chiefly observed in conjunction with collagen deposition in the external granuloma layer. We did not find high involvement of CD163 or CD206-positive cells in the fibrotic process. TGF-β was notable only in keloid and lacaziosis lesions. In conclusion, we have suggested vimentin to be the main myofibroblast general marker of the fibrotic process in all three studied diseases, while endothelial-to-mesenchymal transition (EndoMT) and mesenchymal stem cells (MSCs) and M2 macrophages may not play an important role.
Collapse
Affiliation(s)
- Wagner Luiz Tafuri
- Departamento de Patologia GeralInstituto de Ciências BiológicasUniversidade Federal de Minas GeraisBelo HorizonteBrazil
- Faculdade de Medicina, Departamento de PatologiaUniversidade de São PauloSao PauloBrazil
| | - Thaise Yumie Tomokane
- Laboratório de Patologia das Moléstias Infecciosas – LIM50, Departamento de PatologiaFaculdade de Medicina da Universidade de São PauloSão PauloBrazil
| | | | - Luciane Kanashiro‐Galo
- Faculdade de Medicina, Departamento de PatologiaUniversidade de São PauloSao PauloBrazil
| | | | | | - Carla Pagliari
- Faculdade de Medicina, Departamento de PatologiaUniversidade de São PauloSao PauloBrazil
- Instituto de Assistência Médica ao Servidor Público Estadual e Programa de pós‐graduação em Ciências da SaúdeSão PauloBrazil
| | - Mirian N. Sotto
- Faculdade de Medicina, Departamento de PatologiaUniversidade de São PauloSao PauloBrazil
| |
Collapse
|
2
|
Navarro IC, Ferreira FM, Nakaya HI, Baron MA, Vilar-Pereira G, Pereira IR, Silva AMG, Real JM, De Brito T, Chevillard C, Lannes-Vieira J, Kalil J, Cunha-Neto E, Ferreira LRP. MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes. PLoS Negl Trop Dis 2015; 9:e0003828. [PMID: 26086673 PMCID: PMC4473529 DOI: 10.1371/journal.pntd.0003828] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2014] [Accepted: 05/14/2015] [Indexed: 11/18/2022] Open
Abstract
Chagas disease is caused by the parasite Trypanosoma cruzi, and it begins with a short acute phase characterized by high parasitemia followed by a life-long chronic phase with scarce parasitism. Cardiac involvement is the most prominent manifestation, as 30% of infected subjects will develop abnormal ventricular repolarization with myocarditis, fibrosis and cardiomyocyte hypertrophy by undefined mechanisms. Nevertheless, follow-up studies in chagasic patients, as well as studies with murine models, suggest that the intensity of clinical symptoms and pathophysiological events that occur during the acute phase of disease are associated with the severity of cardiac disease observed during the chronic phase. In the present study we investigated the role of microRNAs (miRNAs) in the disease progression in response to T. cruzi infection, as alterations in miRNA levels are known to be associated with many cardiovascular disorders. We screened 641 rodent miRNAs in heart samples of mice during an acute infection with the Colombiana T.cruzi strain and identified multiple miRNAs significantly altered upon infection. Seventeen miRNAs were found significantly deregulated in all three analyzed time points post infection. Among these, six miRNAs had their expression correlated with clinical parameters relevant to the disease, such as parasitemia and maximal heart rate-corrected QT (QTc) interval. Computational analyses identified that the gene targets for these six miRNAs were involved in networks and signaling pathways related to increased ventricular depolarization and repolarization times, important factors for QTc interval prolongation. The data presented here will guide further studies about the contribution of microRNAs to Chagas heart disease pathogenesis. Chagas’ disease is caused by the protozoan parasite Trypanosoma cruzi and affects 8 million individuals worldwide. The life-long infection begins with a short acute phase, which is associated to parasites circulating in the bloodstream, tissue parasitism, and various signs and symptoms including those related to myocarditis. After resolution of the acute phase, about 30% of those chronically infected will develop abnormal ventricular repolarization with hypertrophy, myocarditis and fibrosis by yet undefined mechanisms. MicroRNAs play a key role in silencing gene expression and are essential elements of the physiology and pathophysiology of the cardiovascular system. Here we describe for the first time the effect of acute T. cruzi infection on host miRNA expression by screening 641 rodent miRNAs in heart samples. A number of miRNAs have significantly altered expression upon infection and several of them correlate with T. cruzi parasitism and electrocardiographic changes. Pathway analysis results suggest that these dysregulated miRNAs can potentially affect gene networks and signaling pathways related to increased ventricular depolarization and repolarization times. Our study provides new insights on miRNA regulation of genes relevant to parasitological and cardiological outcomes.
Collapse
Affiliation(s)
- Isabela Cunha Navarro
- Laboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil
- Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil
- Institute for Investigation in Immunology, iii-INCT, São Paulo, Brazil
| | - Frederico Moraes Ferreira
- Laboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil
- Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil
- Institute for Investigation in Immunology, iii-INCT, São Paulo, Brazil
| | - Helder I. Nakaya
- Department of Clinical Analyses and Toxicology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
| | - Monique Andrade Baron
- Laboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil
- Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil
- Institute for Investigation in Immunology, iii-INCT, São Paulo, Brazil
| | - Gláucia Vilar-Pereira
- Laboratory of Biology of Interactions, Oswaldo Cruz Institute—FIOCRUZ, Rio de Janeiro, Brazil
| | - Isabela Resende Pereira
- Laboratory of Biology of Interactions, Oswaldo Cruz Institute—FIOCRUZ, Rio de Janeiro, Brazil
| | - Ana Maria Gonçalves Silva
- Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil
- Department of Pathology, University of São Paulo School of Medicine, São Paulo, Brazil
| | | | - Thales De Brito
- Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil
- Department of Pathology, University of São Paulo School of Medicine, São Paulo, Brazil
| | | | - Joseli Lannes-Vieira
- Laboratory of Biology of Interactions, Oswaldo Cruz Institute—FIOCRUZ, Rio de Janeiro, Brazil
| | - Jorge Kalil
- Laboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil
- Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil
- Institute for Investigation in Immunology, iii-INCT, São Paulo, Brazil
| | - Edecio Cunha-Neto
- Laboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil
- Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil
- Institute for Investigation in Immunology, iii-INCT, São Paulo, Brazil
- * E-mail:
| | - Ludmila Rodrigues Pinto Ferreira
- Laboratory of Immunology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil
- Division of Clinical Immunology and Allergy, University of São Paulo School of Medicine, São Paulo, Brazil
- Institute for Investigation in Immunology, iii-INCT, São Paulo, Brazil
| |
Collapse
|